Association Between Apolipoprotein B Gene Polymorphisms and the Risk of Coronary Heart Disease (CHD): an Update Meta-Analysis

Jing-Zhan Zhang,Ying-Ying Zheng,Yi-Ning Yang,Xiao-Mei Li,Zhen-Yan Fu,Chuan-Fang Dai,Fen Liu,Bang-Dang Chen,Min-Tao Gai,Yi-Tong Ma,Xiang Xie
DOI: https://doi.org/10.1177/1470320315615047
2016-01-01
Aging and Disease
Abstract:Objective:Polymorphisms in the apolipoprotein B (apoB) gene have been reported to be associated with coronary heart disease (CHD). However, the results on this topic are conflicting. The present study aims to derive a more precise estimation of the relationship between CHD and apoB genetic polymorphisms by meta-analysis. Methods:We identified a total of 54 studies involving 7236, 10,912, and 14,102 individuals, respectively, for EcoRI, XbaI, and SpIns/Del polymorphisms by searching in PubMed, Web of Science, Google Scholar, the Cochrane Library, Wanfang Data, SinoMed, and CNKI. We utilized RevMan 5.0 software to perform the meta-analyses. Results:A significant statistical association between apoB EcoRI polymorphism and CHD was observed under an allelic (p = 0.001, odds ratio (OR) = 1.33, 95% confidence interval (CI) = 1.12–1.57), dominant (p = 0.005, OR = 1.22, 95% CI = 1.06–1.40), and recessive (p = 0.04, OR = 1.33, 95% CI = 1.01–1.74) model. We also found similar association of apoB SpIns/Del polymorphism with CHD. However, we did not find association between apoB XbaI polymorphism and CHD. Conclusion:The current meta-analysis found an association of EcoRI polymorphism and SpIns/Del polymorphism with an increased risk of CHD. No significant association between apoB XbaI polymorphism and CHD we observed in the present study.
What problem does this paper attempt to address?